XPRIZE and Google Announce Winners of Annual STEM-Based Competition, “MOONBOTS”
XPRIZE, the global leader in incentivized prize competitions, and Google today announced the winners of the 2015 MOONBOTS Challenge, also considered the “Google Lunar XPRIZE for Kids.” It is an international competition that inspires the next generation of space explorers and innovators by inviting kids ages 8-17 to design, create and program their own lunar rover, based on a legend or theory that inspires them about the moon.
Next month, the winning teams will embark upon a once-in-a-lifetime trip to Japan to meet the official teams competing for a $30M Google Lunar XPRIZE, a global competition to land a privately funded robot on the moon.
For the first time since the inception of MOONBOTS in 2010, the majority of the winning teams’ members are female — breaking stereotypes in the typically male-dominated fields of science, technology, engineering and mathematics (STEM). The 2015 MOONBOTS winning teams, representing three countries are:
- Team GalacTECHs (Tustin, Calif.) comprised of two girls and two boys ages 8-11, who imagined a future where it’s common practice for people to vacation at a resort on the moon.
- Linked Lunas (Fort Lauderdale, Fla.) comprised of twin sisters Hadley and Delaney, age 9. Their mission is based on a historical tale and scientific theory that hits close to home – that the Earth once had “twin” moons that collided and merged into one.
- Mecaliks (Cuautitlan Izcalli, Mexico) comprised of three girls ages 9-12, who were inspired by Mayan cultural beliefs that time is measured by lunar phases.
- Moonshot (Brooklyn, N.Y. and Naples, Italy) comprised of two boy cousins, ages 10 and 12, who live across the world from each other but share a similar interest in the moon and the way it brings people together – just as it does in their family.
“In addition to showing ingenuity and innovation in their robotic building and programming, all four grand prize winners were creative and imaginative in the way they interpreted their moon ‘tales,’” said Chanda Gonzales, senior director, Google Lunar XPRIZE. “While each entry was unique, they were all incredibly engaging and will provide inspiration for kids all over the world.”
The winning teams will travel to Japan in October to meet up with the Google Lunar XPRIZE teams who are gathering for an annual Team Summit in Tokyo.
“By inspiring and encouraging today’s youth, MOONBOTS is paving the way for the next generation of coders, innovators, space explorers and dreamers,” said Yasemin Denari Southworth, brand marketing manager at Google. “We are proud to build both boys’ and girls’ confidence by supporting their imagination and creativity in a game of skill that’s collaborative and educational. By doing so, we hope to eliminate some environmental and social barriers that can block participation and progress in STEM, especially among young girls.”
The student competition, which began in April, attracted 235 teams from 29 countries who entered phase one by submitting a written or video entry about what inspires them about the moon. Teams are comprised of 2-4 members (ages 8-17) and one team captain at least 18 years old. A panel of judges selected 30 teams to qualify for phase two, each of which was provided one of three platform systems (LEGO MINDSTORMS EV3, VEX IQ, MECCANO Meccanoid G15 KS) to build and program a unique simulated robotic mission based on the moon tale they submitted in phase one. In addition, they were asked to provide a demonstration to the judges via live webcast and contribute to STEM education by sharing their innovation with children and adults in their community.
Since 2010, MOONBOTS has challenged thousands of young people from around the world. In addition to XPRIZE and Google, competition partners include FIRST® LEGO® League, Cogmation Robotics, VEX Robotics Inc., Spin-Master Ltd., the Robotics Education and Competition Foundation (RECF), GeekDad, GeekMom, Robomatter Incorporated and Dexter Industries. More information, including the full list of finalists, can be found at moonbots.org.
About the Google Lunar XPRIZE
The $30M Google Lunar XPRIZE is an unprecedented competition to challenge and inspire engineers and entrepreneurs from around the world to develop low-cost methods of robotic space exploration. To win the Google Lunar XPRIZE, a privately funded team must successfully place a robot on the moon’s surface that explores at least 500 meters and transmits high-definition video and images back to Earth. For more information, visit lunar.xprize.org/.
Eric Desatnik, 310-741-4892
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 18:28 | Pressemelding
Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (http://www.elektroniknet.de), a leading German electronics publication. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180323005646/en/ Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl
Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 16:05 | Pressemelding
Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the
Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 12:52 | Pressemelding
Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal
CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 12:50 | Pressemelding
Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation
Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 12:46 | Pressemelding
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c
Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 12:00 | Pressemelding
Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at www.aitheon.com/news) This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180323005269/en/ Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on